My NCBISign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 97

    1.

    Efficacy dilution in randomized placebo-controlled vaginal microbicide trials.

    Mâsse BR, Boily MC, Dimitrov D, Desai K.

    Emerg Themes Epidemiol. 2009 Oct 9;6:5.PMID: 19818138 [PubMed - in process]Related articlesFree article

    2.

    Will microbicide trials yield unbiased estimates of microbicide efficacy?

    Trussell J, Dominik R.

    Contraception. 2005 Dec;72(6):408-13. Epub 2005 Aug 24.PMID: 16307961 [PubMed - indexed for MEDLINE]Related articles

    3.

    Microbicides for HIV prevention: reality or hope?

    McGowan I.

    Curr Opin Infect Dis. 2010 Feb;23(1):26-31.PMID: 19935418 [PubMed - in process]Related articles

    4.

    Microbicides and HIV prevention: lessons from the past, looking to the future.

    Morris GC, Lacey CJ.

    Curr Opin Infect Dis. 2010 Feb;23(1):57-63.PMID: 19918175 [PubMed - in process]Related articles

    5.

    Microbicides Development Programme: design of a phase III trial to measure the efficacy of the vaginal microbicide PRO 2000/5 for HIV prevention.

    Nunn A, McCormack S, Crook AM, Pool R, Rutterford C, Hayes R.

    Trials. 2009 Oct 27;10:99.PMID: 19860888 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Microbicide safety and effectiveness: an overview of recent clinical trials.

    Poynten M, Brown JM, Sovero M, Millwood IY, Kaldor JM.

    Curr Opin HIV AIDS. 2008 Sep;3(5):574-80.PMID: 19373024 [PubMed]Related articles

    7.

    Using modeling to explore the degree to which a microbicide's sexually transmitted infection efficacy may contribute to the HIV effectiveness measured in phase 3 microbicide trials.

    Vickerman P, Foss A, Watts C.

    J Acquir Immune Defic Syndr. 2008 Aug 1;48(4):460-7.PMID: 18614928 [PubMed - indexed for MEDLINE]Related articles

    8.

    In vitro and in vivo characterization of a potential universal placebo designed for use in vaginal microbicide clinical trials.

    Tien D, Schnaare RL, Kang F, Cohl G, McCormick TJ, Moench TR, Doncel G, Watson K, Buckheit RW, Lewis MG, Schwartz J, Douville K, Romano JW.

    AIDS Res Hum Retroviruses. 2005 Oct;21(10):845-53.PMID: 16225411 [PubMed - indexed for MEDLINE]Related articles

    9.

    A summary of preclinical topical microbicide rectal safety and efficacy evaluations in a pigtailed macaque model.

    Patton DL, Sweeney YT, Paul KJ.

    Sex Transm Dis. 2009 Jun;36(6):350-6.PMID: 19556929 [PubMed - indexed for MEDLINE]Related articles

    10.

    Acceptability of a Carrageenan-Based Candidate Vaginal Microbicide and Matching Placebo: Findings from a Phase II Safety Trial among Women in Chiang Rai, Thailand.

    Jones HE, Chaikummao S, van de Wijgert JH, Friedland BA, Manopaiboon C, Witwatwongwana P, Wankrairot M, Chantharojwong N, Kilmarx PH.

    J Womens Health (Larchmt). 2009 Jul 6. [Epub ahead of print]PMID: 19575689 [PubMed - as supplied by publisher]Related articles

    11.

    Microbicides: a new frontier in HIV prevention.

    McGowan I.

    Biologicals. 2006 Dec;34(4):241-55. Epub 2006 Nov 13. Review.PMID: 17097303 [PubMed - indexed for MEDLINE]Related articles

    12.

    A summary of preclinical topical microbicide vaginal safety and chlamydial efficacy evaluations in a pigtailed macaque model.

    Patton DL, Cosgrove Sweeney YT, Paul KJ.

    Sex Transm Dis. 2008 Oct;35(10):889-97.PMID: 18607310 [PubMed - indexed for MEDLINE]Related articles

    13.

    Microbicides for the prevention of HIV infection in women: an overview of recent trials.

    Rosenberg ZF, Nel A, Heyward W, Mitchnick M.

    Curr Opin HIV AIDS. 2006 Nov;1(6):514-9.PMID: 19372855 [PubMed]Related articles

    14.

    Persisting with prevention: The importance of adherence for HIV prevention.

    Weiss HA, Wasserheit JN, Barnabas RV, Hayes RJ, Abu-Raddad LJ.

    Emerg Themes Epidemiol. 2008 Jul 11;5:8.PMID: 18620578 [PubMed - in process]Related articlesFree article

    15.

    Adherence and its Measurement in Phase 2/3 Microbicide Trials.

    Tolley EE, Harrison PF, Goetghebeur E, Morrow K, Pool R, Taylor D, Tillman SN, van der Straten A.

    AIDS Behav. 2009 Nov 19. [Epub ahead of print]PMID: 19924525 [PubMed - as supplied by publisher]Related articles

    16.

    Vaginal microbicides and the prevention of HIV transmission.

    Cutler B, Justman J.

    Lancet Infect Dis. 2008 Nov;8(11):685-97. Review.PMID: 18992405 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    The future of HIV microbicides: challenges and opportunities.

    Garg AB, Nuttall J, Romano J.

    Antivir Chem Chemother. 2009;19(4):143-50. Review.PMID: 19374141 [PubMed - indexed for MEDLINE]Related articles

    18.

    Microbicide acceptability research: recent findings and evolution across phases of product development.

    Coly A, Gorbach PM.

    Curr Opin HIV AIDS. 2008 Sep;3(5):581-6.PMID: 19373025 [PubMed]Related articles

    19.

    Biomarkers of cervicovaginal inflammation for the assessment of microbicide safety.

    Cummins JE Jr, Doncel GF.

    Sex Transm Dis. 2009 Mar;36(3 Suppl):S84-91. Review.PMID: 19218890 [PubMed - indexed for MEDLINE]Related articles

    20.

    Effects of physiological fluids on physical-chemical characteristics and activity of topical vaginal microbicide products.

    Sassi AB, Isaacs CE, Moncla BJ, Gupta P, Hillier SL, Rohan LC.

    J Pharm Sci. 2008 Aug;97(8):3123-39.PMID: 17922539 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity

    You are here: NCBI > Literature > PubMed
    Write to the Help Desk